Kevin Quon
Insider ownership, small-cap, long-term horizon, dividend investing

Why Intermolecular Is Starting To Look Oversold

Executive Summary:

  • Intermolecular has cornered a unique platform to accelerate the process of research and development.
  • As technology matures, there is a growing need for research efficiency which can directly translate into cost savings and accelerated revenue.
  • While Intermolecular has seen its stock fall, the price drop has failed to reflect the ongoing progress made by the company's business model.
  • Intermolecular has continued to build upon its intellectual property portfolio thereby securing long-term revenue streams from partner companies.


It is not often when the market appears to misjudge a company's fair valuation. However, in the case of Intermolecular, Inc (IMI) this grossly appears to be the case. Intermolecular is the owner of the High Productivity Combinatorial [HPC]...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details